Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
Open Access
- 21 February 2025
- journal article
- review article
- Published by Springer Nature in Cell Death Discovery
- Vol. 11 (1) , 1-16
Abstract
Cholangiocarcinoma (CCA) is a malignant tumor that originates from the bile duct epithelium and with a poor outcome due to lack of effective early diagnostic methods. Surgical resection is the preferred method for cure, but treatment options are limited for advanced diseases, such as distant metastatic or locally progressive tumors. Therefore, it is urgent to explore other new treatment methods. As modern living standards rise, the acceptance of high-fat, high-protein, and high-carbohydrate diets is growing among the public, and the resulting metabolic abnormalities are intimately linked to the initiation and spread of tumors. Metabolic reprogramming is a key mechanism in the process of tumor development and progression and is closely related to cancer cell proliferation, metastasis and drug resistance. Fatty acid (FA) metabolism, an integral component of cancer cell metabolism, can provide an energy source for cancer cells and participate in cell signaling, the regulation of the immune response and the maintenance of homeostasis of the internal environment, which are closely linked to the development and progression of CCA. Therefore, a better understanding of FA metabolism may provide promising strategies for early diagnosis, prognostic assessment and targeted therapy for CCA patients. In this paper, we review the effects of FA metabolism on CCA development and progression, summarize related mechanisms and the existing clinical applications of targeted lipid metabolism in CCA, and explore new targets for CCA metabolic therapy.Keywords
This publication has 138 references indexed in Scilit:
- FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsVirchows Archiv, 2022
- Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsHepatology, 2022
- Imaging mimickers of cholangiocarcinoma: a pictorial reviewAbdominal Radiology, 2022
- Ferroptosis, radiotherapy, and combination therapeutic strategiesProtein & Cell, 2021
- A potential role for aspirin in the prevention and treatment of cholangiocarcinomaInternational Journal of Cancer, 2020
- Expression of fatty-acid-binding protein 5 in intrahepatic and extrahepatic cholangiocarcinoma: the possibility of different energy metabolisms in anatomical locationMedical Molecular Morphology, 2019
- MicroRNA (miR)‐433 and miR‐22 dysregulations induce histone‐deacetylase‐6 overexpression and ciliary loss in cholangiocarcinomaHepatology, 2018
- Linoleic acid induces migration and invasion through FFAR4- and PI3K-/Akt-dependent pathway in MDA-MB-231 breast cancer cellsMedical Oncology, 2017
- Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humansHepatology, 2016
- Prostaglandin E2 receptor EP1 phosphorylate CREB and mediates MMP2 expression in human cholangiocarcinoma cellsMolecular and Cellular Biochemistry, 2013